CNTA CENTESSA PHARMACEUTICALS PLC Stock — fundamentals, financials & AI research · AlgoThesis

Stocks›Basic Materials›CNTA

CNTA

Name: AlgoThesis
Author: algothesis

CENTESSA PHARMACEUTICALS PLC

NasdaqResearch view

Basic Materials · Pharmaceutical Preparations · SEC EDGAR FY 2025-12-31

Price history

Interactive · live data via TradingView

🔒 Click to interact · scroll moves the page

SEC EDGAR · FY 2025-12-31

Revenue$15.0M

Net Income$-197.5M

Gross Profit—

Oper Income$-207.7M

EPS (dil)$-1.46

Rev/sh$0.10

FCF/sh$-1.26

Book/sh$3.41

Cash/sh$0.40

40+ fundamentals from SEC EDGAR (public domain) — deeper than a typical screener's ratio table.

Revenue & Earnings — fiscal year

2022

$6.9M

2023

2024

$15.0M

2025

SEC EDGAR · last 4 FY

USD	FY2022	FY2023	FY2024	FY2025
Revenue	$0	$6.9M	$0	$15.0M
Gross Profit	—	—	—	—
Operating Income	$-212.3M	$-171.3M	$-201.1M	$-207.7M
Net Income	$-216.2M	$-151.1M	$-235.8M

Computed from the SEC EDGAR multi-year statements

GrossOperatingNet

COMMUNITY · $CNTA0 theses

Related Stocks

Loading peers…

Fundamentals sourced from SEC EDGAR filings (public domain). For informational purposes only. Not investment advice.